StockData
GeneDx Holdings Corp. logo

GeneDx Holdings Corp. (WGS) stock

WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$47.29−3.73 (-7.31%)

Close on Nov 17, 2026Market cap $1.41BP/E –Yield –

GeneDx market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

GeneDx's market cap was $1.63B on Nov 10, 2026, against $4.82B a year earlier. Over the last 5 years it ranged from $1.46K to $4.82B, with a median of $846.84M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$1.63B-56.5%
2025Dec 31, 2025$3.76B+78.2%
2024Dec 31, 2024$2.11B+2863.2%
2023Dec 29, 2023$71.16M-28.2%
2022Dec 30, 2022$99.17M+6006654.6%
2021Jan 29, 2021$1.65K+13.3%
2020Dec 31, 2020$1.46K–

More GeneDx figures

See a number that looks wrong?